Wiley Mar 9 2026 In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of anticoagulants, investigators found no evidence of an increase in patients' bleeding or clotting risks, despite previous lab results that raised alarms. The findings are published by Wiley online in  CANCER , a peer-reviewed journal of the American Cancer Society. Thromboembolism, caused by a circulating blood clot that gets stuck and causes an obstruction, is